Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE9211.5022.6 (+0.25 %)
PREV CLOSE ( ) 9188.90
OPEN PRICE ( ) 9136.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 70
TODAY'S LOW / HIGH ( )9108.00 9230.50
52 WK LOW / HIGH ( )6301 10653.05
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 11-07 1979
Management Info
Shilpa Divekar Nirula - Chairman - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone 080 6774 8000

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com/india

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
 Listing : BSE, NSE
NEWS
18Nov AstraZeneca rises on entering into dis
Astrazeneca Pharma India is currently trading at Rs. 9161.15, up by 29.1..
17Nov AstraZeneca enters into distribution s
AstraZeneca Pharma India (AstraZeneca) has entered into distribution ser..
27Oct AstraZeneca Pharma India informs abou
AstraZeneca Pharma India has informed that the Meeting of the Board of D..
04Oct Astrazeneca Pharma gets CDSCO’s nod
Astrazeneca Pharma India has received permission from the Central Drugs..
19Sep AstraZeneca Pharma India informs about
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
MORE
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit542.21157.4
Gross Profit 728.2 1563.6
Operating Profit 813.52946
Net Sales 5590.917162.9
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
up  5689.30 (1.38%)
M.Cap ( in Cr)68024.12
Abbott India (BSE)
up  28869.35 (0.15%)
M.Cap ( in Cr)61345.35
Glaxosmithkline Phar (BSE)
up  2543.10 (1.35%)
M.Cap ( in Cr)43081.65
Wockhardt (BSE)
up  1360.10 (2.16%)
M.Cap ( in Cr)22100.56
RPG Life Sciences (BSE)
up  2228.80 (1.27%)
M.Cap ( in Cr)3686.22
MORE
Shareholding Pattern
PROMOTERS 75%
MUTUAL FUNDS/UTI 5%
NON-INSTITUTION 17.01%
FI/BANKS/INSURANCE 0.19%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
For Nomination, Please Click Here
To Close Account, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.